Clonal Spreading of ST42 Staphylococcus haemolyticus Strains Occurs Possibly Due to fusB and tetK Resistant Genes and Capsule-Related Genes
Open Access
- 24 March 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (7) , 6198
Abstract
Multi-drug resistant Staphylococcus haemolyticus is a frequent nosocomial invasive bacteremia pathogen in hospitals. Our previous analysis showed one of the predominant strains, ST42 originated from ST3, had only one multilocus sequence typing (MLST) variation among seven loci in SH1431; yet no significant differences in biofilm formation observed between ST42 and ST3, suggesting that other factors influence clonal lineage change. Whole genome sequencing was conducted on two isolates from ST42 and ST3 to find phenotypic and genotypic variations, and these variations were further validated in 140 clinical isolates. The fusidic acid- and tetracycline-resistant genes (fusB and tetK) were found only in CGMH-SH51 (ST42). Further investigation revealed consistent resistant genotypes in all isolates, with 46% and 70% of ST42 containing fusB and tetK, respectively. In contrast, only 23% and 4.2% ST3 contained these two genes, respectively. The phenotypic analysis also showed that ST42 isolates were highly resistant to fusidic acid (47%) and tetracycline (70%), compared with ST3 (23% and 4%, respectively). Along with drug-resistant genes, three capsule-related genes were found in higher percentage distributions in ST42 than in ST3 isolates. Our findings indicate that ST42 could become endemic in Taiwan, further constitutive surveillance is required to prevent the spread of this bacterium.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 111-2811-B-182A-011, CMRPG3L1781, CMRPG3N0091)
- Chang Gung Memorial Hospital, Linkou (MOST 111-2811-B-182A-011, CMRPG3L1781, CMRPG3N0091)
This publication has 48 references indexed in Scilit:
- Identification of fusB -Mediated Fusidic Acid Resistance Islands in Staphylococcus epidermidis IsolatesAntimicrobial Agents and Chemotherapy, 2011
- Fusidic Acid Resistance Determinants in Staphylococcus aureus Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2010
- Fusidic Acid Resistance Rates and Prevalence of Resistance Mechanisms among Staphylococcus spp. Isolated in North America and Australia, 2007-2008Antimicrobial Agents and Chemotherapy, 2010
- Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)Journal of Antimicrobial Chemotherapy, 2010
- Biofilm Formation by Staphylococcus haemolyticusJournal of Clinical Microbiology, 2009
- Distribution and expression of macrolide resistance genes in coagulase-negative staphylococciClinical Microbiology and Infection, 2007
- Fusidic acid resistance, mediated by fusB, in bovine coagulase-negative staphylococciJournal of Antimicrobial Chemotherapy, 2006
- Capsular Polysaccharides and Their Role in Virulence2004
- Staphylococcus aureusCapsular PolysaccharidesClinical Microbiology Reviews, 2004
- Contribution of Clumping Factor B to Pathogenesis of Experimental Endocarditis due to Staphylococcus aureusInfection and Immunity, 2000